- Diagnostic Différentiel
Drug Information for CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP): OVERDOSAGE
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP)
- Liens externes liés à CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP)
Long-term clinical trials have been conducted with dosages up to 200 mg of CASODEX daily and these dosages have been well tolerated. A single dose of CASODEX that results in symptoms of an overdose considered to be life-threatening has not been established.
There is no specific antidote; treatment of an overdose should be symptomatic.
In the management of an overdose with CASODEX, vomiting may be induced if the patient is alert. It should be remembered that, in this patient population, multiple drugs may have been taken. Dialysis is not likely to be helpful since CASODEX is highly protein bound and is extensively metabolized. General supportive care, including frequent monitoring of vital signs and close observation of the patient, is indicated.
- Drug Information Provided by National Library of Medicine (NLM).